Therapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant Gram-positive bacteria

Simple item page
dc.contributor.authorXie, Yingqiu
dc.contributor.authorLiu, Gaomin
dc.contributor.authorYang, Fan
dc.contributor.authorLi, Fangfang
dc.contributor.authorLi, Zhongjie
dc.contributor.authorLang, Yange
dc.contributor.authorShen, Bingzheng
dc.contributor.authorWu, Yingliang
dc.contributor.authorLi, Wenxin
dc.contributor.authorHarrison, Patrick L.
dc.contributor.authorStrong, Peter N.
dc.contributor.authorMiller, Keith
dc.contributor.authorCao, Zhijian
dc.date.accessioned2019-11-04T09:48:21Z
dc.date.available2019-11-04T09:48:21Z
dc.date.issued2018-05-28
dc.description.abstractThe alarming rise in the prevalence of antibiotic resistance among pathogenic bacteria poses a unique challenge for the development of effective therapeutic agents. Antimicrobial peptides (AMPs) have attracted a great deal of attention as a possible solution to the increasing problem of antibiotic-resistant bacteria. Marcin-18 was identified from the scorpion Mesobuthus martensii at both DNA and protein levels. The genomic sequence revealed that the marcin-18 coding gene contains a phase-I intron with a GT-AG splice junction located in the DNA region encoding the N-terminal part of signal peptide. The peptide marcin-18 was also isolated from scorpion venom. A protein sequence homology search revealed that marcin-18 shares extremely high sequence identity to the AMPs meucin-18 and megicin-18. In vitro, chemically synthetic marcin-18 and its homologs (meucin-18 and megicin-18) showed highly potent inhibitory activity against Gram-positive bacteria, including some clinical antibiotic-resistant strains. Importantly, in a mouse acute peritonitis model, these peptides significantly decreased the bacterial load in ascites and rescued nearly all mice heavily infected with clinical methicillin-resistant Staphylococcus aureus from lethal bacteremia. Peptides exerted antimicrobial activity via a bactericidal mechanism and killed bacteria through membrane disruption. Taken together, marcin-18 and its homologs have potential for development as therapeutic agents for treating antibiotic-resistant, Gram-positive bacterial infections.en_US
dc.identifier.citationLiu, G., Yang, F., Li, F., Li, Z., Lang, Y., Shen, B., ... Cao, Z. (2018). Therapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant Gram-positive bacteria. Frontiers in Microbiology, 9(MAY), [1159]. https://doi.org/10.3389/fmicb.2018.01159en_US
dc.identifier.urihttps://doi.org/10.3389/fmicb.2018.01159
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/4288
dc.language.isoenen_US
dc.publisherNazarbayev University School of Sciences and Humanitiesen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.titleTherapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant Gram-positive bacteriaen_US
dc.typeArticleen_US
workflow.import.sourcescience

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
fmicb-09-01159.pdf
Size:
4.12 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Articles